We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Ryder
R
$10.3B
| $7.05M | 0.01% |
129,848
+719
| +0.6% | +$37.4K |
|
1052
Banner Corp
BANR
$2.44B
| $7.04M | 0.01% |
124,477
+12,139
| +11% | +$672K |
|
1053
Essential Properties Realty Trust
EPRT
$6.64B
| $7.04M | 0.01% |
283,934
+161,958
| +133% | +$4.07M |
|
1054
Chemours
CC
$2.7B
| $7.03M | 0.01% |
388,708
-32,733
| -8% | -$544K |
|
|
TPH
1055
DELISTED
Tri Pointe Homes
TPH
| $7.03M | 0.01% |
451,214
-591
| -0.1% | -$9.1K |
|
1056
Navient
NAVI
$880M
| $7M | 0.01% |
512,074
-14,024
| -3% | -$189K |
|
1057
Sally Beauty Holdings
SBH
$1.58B
| $6.98M | 0.01% |
382,684
-14,490
| -4% | -$252K |
|
1058
Belden
BDC
$4.98B
| $6.96M | 0.01% |
126,466
+1,671
| +1% | +$89.3K |
|
1059
Matador Resources
MTDR
$6.06B
| $6.94M | 0.01% |
386,254
+17,287
| +5% | +$258K |
|
1060
Bath & Body Works
BBWI
$4.24B
| $6.94M | 0.01% |
473,520
+44,091
| +10% | +$637K |
|
1061
Dorman Products
DORM
$4.42B
| $6.94M | 0.01% |
91,598
+5,463
| +6% | +$413K |
|
1062
HEICO Corp Class A
HEI.A
$37.2B
| $6.93M | 0.01% |
77,380
+1,562
| +2% | +$149K |
|
1063
Entegris
ENTG
$22B
| $6.92M | 0.01% |
138,224
+2,712
| +2% | +$131K |
|
1064
Hexcel
HXL
$7.88B
| $6.92M | 0.01% |
94,424
+2,117
| +2% | +$163K |
|
|
ATH
1065
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $6.91M | 0.01% |
146,929
+6
| +0% | +$261 |
|
1066
CoreCivic
CXW
$2.98B
| $6.9M | 0.01% |
397,031
-1,326
| -0.3% | -$21K |
|
1067
NMI Holdings
NMIH
$3.34B
| $6.88M | 0.01% |
207,349
+11,414
| +6% | +$357K |
|
1068
Acadia Pharmaceuticals
ACAD
$4.65B
| $6.88M | 0.01% |
160,777
+13,709
| +9% | +$596K |
|
1069
Under Armour
UAA
$2.92B
| $6.87M | 0.01% |
318,212
+13,481
| +4% | +$262K |
|
|
EPAY
1070
DELISTED
Bottomline Technologies Inc
EPAY
| $6.86M | 0.01% |
127,917
+7,169
| +6% | +$326K |
|
1071
Forward Air
FWRD
$484M
| $6.82M | 0.01% |
97,478
+5,168
| +6% | +$350K |
|
1072
Myriad Genetics
MYGN
$303M
| $6.81M | 0.01% |
249,931
+15,208
| +6% | +$418K |
|
1073
Cabot Corp
CBT
$4.23B
| $6.8M | 0.01% |
143,008
-3,331
| -2% | -$155K |
|
1074
Hope Bancorp
HOPE
$1.83B
| $6.77M | 0.01% |
455,823
+22,324
| +5% | +$324K |
|
1075
CareTrust REIT
CTRE
$9.65B
| $6.77M | 0.01% |
328,095
+22,991
| +8% | +$503K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.